CELESTICA INC

CLSNYSE

Earnings Jan 26US Equity

$282.75▼ $17.06 (−5.69%)

🌙 After hours$273.80▼ 3.17%Regular close · extended-hours price shown

🔔

Track CLS

Get earnings, price moves & breaking news on Telegram

Track

24h▼ 5.7%

7d▲ 8.9%

14d▼ 6.9%

30d▼ 21.7%

ytd▼ 4.4%

1y▼ 16.9%

🏦Market Cap

$35.66B

Mid Cap

📈Revenue Growth (YoY)

47.3%

High Growth

📊Gross Margin

11.9%

Thin

💵FCF Margin

3.3%

Moderate

⚖️P/S Ratio

2.4x

Cheap

Otter Score

—

Insufficient data

CELESTICA INC

CLS

Analyst Ratings

Price

$282.75

Total

Raised

Lowered

Avg PT

$450.82

H / L

$520 / $375

Institution	Action	Rating	Date		Upside
UBS	Reiterated	Buy	2026-10-28	$430.00	+52.10%
Barclays	Reiterated	Overweight	2026-10-28	$414.00	+46.40%
Citigroup	Reiterated	Buy	2026-10-28	—	—
JP Morgan	Reiterated	Overweight	2026-07-29	—	—
Wolfe Research	Reiterated	Outperform	2026-07-29	$475.00	+68.00%
Susquehanna	Reiterated	Positive	2026-04-29	$510.00	+80.40%
RBC Capital	Reiterated	Outperform	2026-04-29	$450.00	+59.20%
TD Cowen	Upgraded	Hold → Buy	2026-04-29	—	—
BMO Capital	Reiterated	Outperform	2026-04-24	$400.00	+41.50%
B of A Securities	Reiterated	Buy	2026-04-20	—	—
CIBC	Reiterated	Outperform	2026-03-11	$500.00	+76.80%
Goldman Sachs	Reiterated	Buy	2025-12-01	$435.00	+53.80%
TD Securities	Reiterated	Hold	2025-10-29	$430.00	+52.10%
Stifel	Reiterated	Buy	2025-10-29	—	—
Canaccord Genuity	Reiterated	Buy	2025-07-30	$70.00	−75.20%
Argus Research	Reiterated	Buy	2025-04-29	$58.00	−79.50%
ScotiaBank	Reiterated	Sector Perform	2020-07-30	—	—
Scotiabank	Reiterated	Sector Perform	2020-07-30	—	—
Macquarie	Downgraded	Outperform → Neutral	2019-02-01	—	—
B. Riley FBR	Reiterated	Neutral	2018-05-05	—	—
Stifel Nicolaus	Reiterated	Hold	2018-01-25	$500.00	+76.80%
Standpoint Research	Upgraded	Hold → Buy	2017-08-17	—	—
Scotia Howard Weil	Upgraded	Sector Perform → Sector Outperform	2016-01-29	—	—
B. Riley Securities	Reiterated	Neutral	2016-01-28	—	—
Raymond James	Downgraded	Outperform → Market Perform	2014-06-24	—	—
Paradigm Capital	Upgraded	Hold → Buy	2013-10-23	—	—
Salman Partners	Upgraded	Hold → Buy	2013-10-23	—	—
Deutsche Bank	Reiterated	Hold	2013-01-23	—	—

Institution

UBS

Reiterated · Buy · 2026-10-28

$430.00

+52.10%

Barclays

Reiterated · Overweight · 2026-10-28

$414.00

+46.40%

Citigroup

Reiterated · Buy · 2026-10-28

—

JP Morgan

Reiterated · Overweight · 2026-07-29

—

Wolfe Research

Reiterated · Outperform · 2026-07-29

$475.00

+68.00%

Susquehanna

Reiterated · Positive · 2026-04-29

$510.00

+80.40%

RBC Capital

Reiterated · Outperform · 2026-04-29

$450.00

+59.20%

TD Cowen

Upgraded · Hold → Buy · 2026-04-29

—

BMO Capital

Reiterated · Outperform · 2026-04-24

$400.00

+41.50%

B of A Securities

Reiterated · Buy · 2026-04-20

—

CIBC

Reiterated · Outperform · 2026-03-11

$500.00

+76.80%

Goldman Sachs

Reiterated · Buy · 2025-12-01

$435.00

+53.80%

TD Securities

Reiterated · Hold · 2025-10-29

$430.00

+52.10%

Stifel

Reiterated · Buy · 2025-10-29

—

Canaccord Genuity

Reiterated · Buy · 2025-07-30

$70.00

−75.20%

Argus Research

Reiterated · Buy · 2025-04-29

$58.00

−79.50%

ScotiaBank

Reiterated · Sector Perform · 2020-07-30

—

Scotiabank

Reiterated · Sector Perform · 2020-07-30

—

Macquarie

Downgraded · Outperform → Neutral · 2019-02-01

—

B. Riley FBR

Reiterated · Neutral · 2018-05-05

—

Stifel Nicolaus

Reiterated · Hold · 2018-01-25

$500.00

+76.80%

Standpoint Research

Upgraded · Hold → Buy · 2017-08-17

—

Scotia Howard Weil

Upgraded · Sector Perform → Sector Outperform · 2016-01-29

—

B. Riley Securities

Reiterated · Neutral · 2016-01-28

—

Raymond James

Downgraded · Outperform → Market Perform · 2014-06-24

—

Paradigm Capital

Upgraded · Hold → Buy · 2013-10-23

—

Salman Partners

Upgraded · Hold → Buy · 2013-10-23

—

Deutsche Bank

Reiterated · Hold · 2013-01-23

—

One row per institution · price target from the firm's latest published target

StockOtter · stockotter.space